AirSculpt Technologies, Inc. (AIRS)
NASDAQ: AIRS · IEX Real-Time Price · USD
5.63
-0.02 (-0.35%)
Apr 24, 2024, 4:00 PM EDT - Market closed

Company Description

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States.

The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure.

It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool.

In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas.

The company's body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure.

It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.

AirSculpt Technologies, Inc.
AirSculpt Technologies logo
Country United States
Founded 2012
IPO Date Oct 29, 2021
Industry Medical Care Facilities
Sector Healthcare
Employees 381
CEO Todd Magazine

Contact Details

Address:
1111 Lincoln Road, Suite 802
Miami Beach, Florida 33139
United States
Phone (786) 709-9690
Website elitebodysculpture.com

Stock Details

Ticker Symbol AIRS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $11.00
CIK Code 0001870940
CUSIP Number 009496100
ISIN Number US0094961002
Employer ID 87-1471855
SIC Code 8011

Key Executives

Name Position
Dr. Aaron J. Rollins M.D. Founder and Executive Chairman
Todd Magazine Chief Executive Officer, President and Director
Dennis Dean Chief Financial Officer
Stephanie Evans Greene Chief Marketing Officer

Latest SEC Filings

Date Type Title
Mar 27, 2024 ARS Filing
Mar 27, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 27, 2024 DEF 14A Other definitive proxy statements
Feb 27, 2024 10-K Annual Report
Feb 27, 2024 8-K Current Report
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 13, 2023 10-Q Quarterly Report
Nov 9, 2023 8-K Current Report
Oct 5, 2023 8-K Current Report
Sep 29, 2023 8-K Current Report